Renal Biomarkers Market Forecast 2026–2035 Highlights Precision Diagnostics Boom
The global Renal Biomarkers Market was valued at approximately USD 1.59 billion in 2025 and is projected to reach nearly USD 3.37 billion by 2035. The market is anticipated to expand at a compound annual growth rate (CAGR) of 7.8% during the forecast period from 2026 to 2035. The growth trajectory of the market is supported by the increasing global burden of chronic kidney diseases (CKD), rising incidences of diabetes and hypertension, growing adoption of precision diagnostics, and expanding investments in biomarker research and clinical nephrology.
